Targeting drug-resistant mutations in ALK
Crossref DOI link: https://doi.org/10.1038/s43018-022-00390-1
Published Online: 2022-06-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
He, Liu
Dar, Arvin C. http://orcid.org/0000-0003-0318-4848
Text and Data Mining valid from 2022-06-20
Version of Record valid from 2022-06-20
Article History
First Online: 20 June 2022
Competing interests
: A.C.D. is a founder, shareholder, consultant and advisory board member of Nested Therapeutics.